Sample Page
Author:
Eikon Therapeutics, Inc.
Posted Date:
June 8, 2026
Eikon Therapeutics Announces the Appointment of Ma. Fatima D. Francisco to its Board of Directors
Eikon Therapeutics, Inc.
June 8, 2026
Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology
Eikon Therapeutics, Inc.
May 30, 2026
Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology
Eikon Therapeutics, Inc.
May 22, 2026
Eikon Therapeutics Reports First Quarter 2026 Financial Results and Provides Clinical Updates
Eikon Therapeutics, Inc.
May 11, 2026
Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates
Eikon Therapeutics, Inc.
March 30, 2026
Eikon Therapeutics Announces Pricing of Upsized Initial Public Offering
Eikon Therapeutics, Inc.
February 7, 2026
